InspireMD Return on Tangible Equity 2013-2025 | NSPR
Current and historical return on tangible equity values for InspireMD (NSPR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| InspireMD Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.05B | $0.06B | -124.32% |
| 2025-06-30 | $-0.04B | $0.02B | -131.20% |
| 2025-03-31 | $-0.04B | $0.03B | -94.74% |
| 2024-12-31 | $-0.03B | $0.04B | -80.50% |
| 2024-09-30 | $-0.03B | $0.04B | -68.71% |
| 2024-06-30 | $-0.03B | $0.05B | -60.61% |
| 2024-03-31 | $-0.02B | $0.04B | -53.33% |
| 2023-12-31 | $-0.02B | $0.04B | -53.15% |
| 2023-09-30 | $-0.02B | $0.04B | -63.33% |
| 2023-06-30 | $-0.02B | $0.05B | -76.77% |
| 2023-03-31 | $-0.02B | $0.01B | -97.44% |
| 2022-12-31 | $-0.02B | $0.02B | -80.00% |
| 2022-09-30 | $-0.02B | $0.02B | -64.29% |
| 2022-06-30 | $-0.02B | $0.03B | -53.54% |
| 2022-03-31 | $-0.02B | $0.03B | -45.07% |
| 2021-12-31 | $-0.02B | $0.03B | -38.46% |
| 2021-09-30 | $-0.02B | $0.04B | -44.78% |
| 2021-06-30 | $-0.01B | $0.04B | -48.15% |
| 2021-03-31 | $-0.01B | $0.04B | -55.00% |
| 2020-12-31 | $-0.01B | $0.01B | -102.56% |
| 2020-09-30 | $-0.01B | $0.01B | -112.50% |
| 2020-06-30 | $-0.01B | $0.01B | -124.14% |
| 2020-03-31 | $-0.01B | $0.00B | -163.64% |
| 2019-12-31 | $-0.01B | $0.01B | -160.00% |
| 2019-09-30 | $-0.01B | $0.01B | -124.14% |
| 2019-06-30 | $-0.01B | $0.01B | -112.50% |
| 2019-03-31 | $-0.01B | $0.01B | -106.67% |
| 2018-12-31 | $-0.01B | $0.01B | -112.00% |
| 2018-09-30 | $-0.01B | $0.01B | -231.58% |
| 2018-06-30 | $-0.01B | $0.00B | -366.67% |
| 2018-03-31 | $-0.01B | $0.00B | -342.86% |
| 2017-12-31 | $-0.01B | $0.00B | -247.62% |
| 2017-09-30 | $-0.01B | $0.00B | -163.64% |
| 2017-06-30 | $-0.01B | $0.01B | -150.00% |
| 2017-03-31 | $-0.01B | $0.01B | -276.92% |
| 2016-12-31 | $-0.01B | $0.00B | -1600.00% |
| 2016-09-30 | $-0.01B | $0.01B | 720.00% |
| 2016-06-30 | $-0.01B | $-0.01B | 366.67% |
| 2016-03-31 | $-0.01B | $0.00B | 1040.00% |
| 2015-12-31 | $-0.02B | $0.00B | -2133.33% |
| 2015-09-30 | $-0.02B | $0.00B | -3600.00% |
| 2015-06-30 | $-0.02B | $0.00B | 2100.00% |
| 2015-03-31 | $-0.03B | $0.01B | 1000.00% |
| 2014-12-31 | $-0.03B | $0.00B | 866.67% |
| 2014-06-30 | $-0.02B | $0.00B | -378.95% |
| 2014-03-31 | $-0.03B | $0.00B | -263.16% |
| 2013-06-30 | $-0.03B | $0.02B | -1018.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.073B | $0.007B |
| InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $198.062B | 23.05 |
| Intuitive Surgical (ISRG) | United States | $176.187B | 67.96 |
| IDEXX Laboratories (IDXX) | United States | $51.802B | 49.63 |
| Edwards Lifesciences (EW) | United States | $46.035B | 30.99 |
| Alcon (ALC) | Switzerland | $39.268B | 26.46 |
| IQVIA Holdings (IQV) | United States | $30.174B | 16.30 |
| Mettler-Toledo (MTD) | United States | $28.306B | 32.55 |
| DexCom (DXCM) | United States | $26.580B | 36.64 |
| STERIS (STE) | Ireland | $23.878B | 24.15 |
| Waters (WAT) | United States | $19.603B | 25.07 |
| Coloplast (CLPBY) | Denmark | $17.488B | 26.76 |
| Hologic (HOLX) | United States | $16.763B | 17.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.540B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.942B | 11.56 |
| Penumbra (PEN) | United States | $13.247B | 93.18 |
| Globus Medical (GMED) | United States | $11.813B | 24.79 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.254B | 23.24 |
| Sysmex ADR (SSMXY) | Japan | $6.295B | 20.00 |
| Glaukos (GKOS) | United States | $6.262B | 0.00 |
| Teleflex (TFX) | United States | $4.727B | 7.53 |
| TransMedics (TMDX) | United States | $4.555B | 53.97 |
| LivaNova (LIVN) | United Kingdom | $3.627B | 19.60 |
| Integer Holdings (ITGR) | United States | $3.055B | 14.34 |
| Veracyte (VCYT) | United States | $2.845B | 32.42 |
| Elekta AB (EKTAY) | Sweden | $2.250B | 21.05 |
| Nihon Kohden (NHNKY) | Japan | $2.036B | 22.47 |
| UFP Technologies (UFPT) | United States | $2.032B | 26.83 |
| Alphatec Holdings (ATEC) | United States | $2.001B | 0.00 |
| Artivion (AORT) | United States | $1.900B | 87.17 |
| Pulse Biosciences (PLSE) | United States | $1.711B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.593B | 0.00 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.333B | 0.00 |
| IRadimed (IRMD) | United States | $1.311B | 58.90 |
| OPKO Health (OPK) | United States | $0.960B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.871B | 4.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.702B | 14.00 |
| SiBone (SIBN) | United States | $0.661B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.632B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.617B | 35.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.13 |
| NeuroPace (NPCE) | United States | $0.485B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.469B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.335B | 55.88 |
| RxSight (RXST) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.236B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.129B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.127B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| Solana (HSDT) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |